These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34077091)

  • 21. Motivational interviewing to promote long-acting reversible contraception among Rwandan couples wishing to prevent or delay pregnancy.
    Mukamuyango J; Ingabire R; Parker R; Nyombayire J; Easter SR; Wall KM; Tichacek A; Nyirazinyoye L; Kaslow N; Allen S; Karita E
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S919.e1-S919.e12. PubMed ID: 31838122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-year continuation of reversible contraception.
    Diedrich JT; Zhao Q; Madden T; Secura GM; Peipert JF
    Am J Obstet Gynecol; 2015 Nov; 213(5):662.e1-8. PubMed ID: 26259905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormonal implants: contraception for a new century.
    Darney PD
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
    Fleming D; Davie J; Glasier A
    Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subdermal contraceptive implants.
    Peralta O; Diaz S; Croxatto H
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levonorgestrel subdermal implants. Contraception on trial.
    Frank ML; DiMaria C
    Drug Saf; 1997 Dec; 17(6):360-8. PubMed ID: 9429835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience of Thai women in Bangkok with Norplant-2 implants.
    Chompootaweep S; Kochagarn E; Tang-Usaha J; Theppitaksak B; Dusitsin N
    Contraception; 1998 Oct; 58(4):221-5. PubMed ID: 9866003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contraception with subdermal levonorgestrel implants as an alternative to surgical contraception at Ilorin, Nigeria.
    Fakeye O
    Int J Gynaecol Obstet; 1991 Aug; 35(4):331-6. PubMed ID: 1682181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors.
    Akhter H; Dunson TR; Amatya RN; Begum K; Chowdhury T; Dighe N; Krueger SL; Rahman S
    Contraception; 1993 Jun; 47(6):569-82. PubMed ID: 8334891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
    Buckshee K; Chatterjee P; Dhall GI; Hazra MN; Kodkany BS; Lalitha K; Logambal A; Manchanda P; Nanda UK; RaiChoudhury G
    Contraception; 1995 Apr; 51(4):237-42. PubMed ID: 7796589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
    Wilson S; Tennant C; Sammel MD; Schreiber C
    Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 5-year clinical evaluation of Norplant implants in Senegal.
    Ba MG; Moreau JC; Sokal D; Dunson R; Dao B; Kouedou D; Diadhiou F
    Contraception; 1999 Jun; 59(6):377-81. PubMed ID: 10518232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the acceptability of Norplant contraceptive in four patient populations.
    Dugoff L; Jones OW; Allen-Davis J; Hurst BS; Schlaff WD
    Contraception; 1995 Jul; 52(1):45-9. PubMed ID: 8521714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Norplant implants in the UK: first year continuation and removals.
    Peers T; Stevens JE; Graham J; Davey A
    Contraception; 1996 Jun; 53(6):345-51. PubMed ID: 8773421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project.
    Allsworth JE; Secura GM; Ajibade OO; Peipert JF
    J Womens Health (Larchmt); 2018 May; 27(5):599-606. PubMed ID: 29768114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
    Matusiewicz AK; Melbostad HS; Heil SH
    Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new delivery system for contraceptive steroids.
    Segal S
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1090-2. PubMed ID: 3118719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.